192
Participants
Start Date
December 31, 2025
Primary Completion Date
August 31, 2027
Study Completion Date
September 30, 2027
Treatment dose antibiotic in combination with methenamine hippurate
"Arm A includes treatment with one of three treatment dose antibiotic options, selected by the treating clinician, in combination with methenamine hippurate. Participants allocated to this arm will receive combination therapy, consisting of one of the following antibiotics:~* Cefalexin (500mg four times daily), or~* Nitrofurantoin (100mg twice daily), or~* Trimethoprim (200mg twice daily) in combination with Methenamine Hippurate (1g twice daily) for 12 weeks."
Prophylactic dose antibiotic or methenamine hippurate monotherapy
"Arm B includes treatment with one of four prophylactic dose antibiotics or methenamine hippurate, but not both, selected by the treating clinician. Participants in this arm will receive monotherapy of one of the following:~* Amoxicillin (250mg once daily), or~* Cefalexin (125mg once daily), or~* Nitrofurantoin (50mg once daily), or~* Trimethoprim (100mg once daily), or~* Methenamine Hippurate (1g twice daily) for 12 weeks."
Guy's and St Thomas' NHS Foundation Trust, London
University College London Hospitals NHS Foundation Trust, London
Whittington Health NHS Trust, London
Manchester University NHS Foundation Trust, Manchester
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne
University College, London
OTHER